We sincerely apologize for the technical issues during the ONE 172 PPV on watch.ONEFC.com. As a token of appreciation for your patience, we’re making the rest of the event free to watch on ONE’s ...

With the global approach to AI regulation at a turning point, many countries are reconsidering their strict regulatory frameworks. In February 2025, Japan’s AI Policy Study Group, part of the ...

A Boston biotech try­ing to bring trans­fer RNA (tR­NA) bi­ol­o­gy to the drug de­vel­op­ment field has shut­tered op­er­a­tions, End­points News has learned.

Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an FDA-approved PD-L1 inhibitor. Japan's Ono Pharmaceutical bought an antisense ...

Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, gastrointestinal (GI) and hematology, while pushing the Japanese company ...